✦ LIBER ✦
Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone as Adjuvant Treatment of Operable, Node-Positive, Elderly Breast Cancer Patients: 6-Year Follow-up Results of the French Adjuvant Study Group 08 Trial
✍ Scribed by Theriault, R.L.
- Book ID
- 122953994
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 62 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1043-321X
No coin nor oath required. For personal study only.